DoW, Ovarian Cancer, Investigator-Initiated Research Award

The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. The award mechanism supports research projects that focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. Key aspects of the opportunity include: • The maximum period of performance is 4 years • The maximum allowable funding for the entire period of performance is $2.8 million for total costs • Applications require preliminary data • Research aimed at extending the lives of advanced-state and recurrent patients is encouraged • Applications cannot support clinical trials • A partnering Principal Investigator (PI) option is available, where two investigators can collaborate on a single project